Concepedia
Statistics
Publications
11
Citations
341
H-Index
Active since
2011
Affiliations
Takeda (United States)(Current)
Soochow University
Second Affiliated Hospital of Soochow University
Zhejiang Cancer Hospital
University of Kentucky
Jing Xu is an author at Takeda (United States) specializing in pharmacology, immunology, and medicine.
Publications per year
2011–2020
Vedolizumab, a monoclonal antibody to the gut homing α4β7 integrin, does not affect cerebrospinal fluid T-lymphocyte immunophenotype
Catherine Milch, Tim Wyant, Jing Xu et al. · Journal of Neuroimmunology · 2013 · 77 citations
Life Sciences, Immunology, Pharmacology +13
EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model
Amit Singh, Jing Xu, George Mattheolabakis et al. · Nanomedicine Nanotechnology Biology and Medicine · 2015 · 66 citations · Full text
Pharmacy, Oncology, Pharmacology +16
Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells
Qing Gu, Yan He, Jianfeng Ji et al. · Oncotarget · 2015 · 60 citations · Full text
Medicine, Cancer Biology, Radiation Oncology +17
Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
Jian Huan, Yi Gao, Jing Xu et al. · PubMed · 2015 · 34 citations
Medicine, Oncology, Pathology +17
What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn’s Disease Treated With Vedolizumab?
Jing Xu, Huifang Liang, Fatima Bhayat · Inflammatory Bowel Diseases · 2018 · 26 citations · Full text
Pharmacy, Immunology, Pharmacotherapy +16
1–5 of 11